The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...
The obesity market size is projected to witness growth from 2024 to 2034 due to the rising prevalence of obesity. This expansion is expected to be fu ...
State must walk a fine line between playing the green card in Washington and standing tall alongside EU colleagues ...
Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...
Multiple GeForce RTX 5090 cards in the wild are showing fewer ROPs in GPU-Z than what they're supposed to have.
Stocktwits on MSN20h
Eli Lilly Remains JPMorgan's Top Biopharma Pick For 2025, But Gilead And Bristol Myers Also Gain Praise — Is Retail On Board?JPMorgan is sticking with Eli Lilly (LLY) as its top biopharma pick for 2025, while also highlighting Gilead Sciences (GILD) ...
Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...
Overview of the Migraine Drugs MarketThe global Migraine Drugs Market is valued at $6.37 billion in 2024 and is projected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback